Disclosed herein are pharmaceutical composition comprising a compound of formula (I) wherein the substituents are as defined within the specification, a further therapeutic agent. Such a composition is useful in the treatment of diseases which involve cell proliferation, migration or apoptosis of cancer cells, or angiogensis.
